Kalvista Pharmaceuticals Inc (KALV)
Aktien-Chart
Earnings
Value bought
Letzte 90 Tage
Value sold
Letzte 90 Tage
Net insiders buying
Letzte 90 Tage
Trades (buy and sell)
Letzte 90 Tage
| Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion | Insider und/oder position |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Wert | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-04-11 | 2025-04-09 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
1.000
+0.5%
9,42235.500 USD |
1.000 +0.5% | 9,42 | 100.000 USD | |
| 2025-03-10 | 2025-03-07 | V Verkauf |
CHIEF EXECUTIVE OFFICER Geschäftsführender Verwaltungsratsmitglied |
6.669
-2.3%
11,9779.828 USD |
6.669 -2.3% | 11,97 | 79.828 USD | |
| 2025-02-25 | 2025-02-24 | V Verkauf |
CHIEF MEDICAL OFFICER Führungsperson |
2.394
-2.3%
10,0223.988 USD |
2.394 -2.3% | 10,02 | 23.988 USD | |
| 2025-02-25 | 2025-02-24 | V Verkauf |
CHIEF DEVELOPMENT OFFICER Führungsperson |
1.918
-2.0%
10,0219.218 USD |
1.918 -2.0% | 10,02 | 19.218 USD | |
| 2025-02-19 | 2025-02-18 | V Verkauf |
CHIEF DEVELOPMENT OFFICER Führungsperson |
2.601
-2.7%
9,8225.553 USD |
2.601 -2.7% | 9,82 | 25.553 USD | |
| 2025-02-19 | 2025-02-18 | V Verkauf |
CHIEF EXECUTIVE OFFICER Geschäftsführender Verwaltungsratsmitglied |
5.104
-1.8%
9,8250.143 USD |
5.104 -1.8% | 9,82 | 50.143 USD | |
| 2025-02-19 | 2025-02-18 | V Verkauf |
CHIEF MEDICAL OFFICER Führungsperson |
3.125
-3.0%
9,8230.701 USD |
3.125 -3.0% | 9,82 | 30.701 USD | |
| 2025-02-14 | 2025-02-13 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
61.700
+1.2%
9,33575.661 USD |
61.700 +1.2% | 9,33 | 575.661 USD | |
| 2025-02-14 | 2025-02-12 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
100.000
+2.0%
9,23923.000 USD |
100.000 +2.0% | 9,23 | 923.000 USD | |
| 2025-02-11 | 2025-02-11 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
26.703
+0.5%
9,18245.134 USD |
26.703 +0.5% | 9,18 | 245.134 USD | |
| 2025-02-11 | 2025-02-10 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
4.137
+0.1%
9,1437.812 USD |
4.137 +0.1% | 9,14 | 37.812 USD | |
| 2025-02-11 | 2025-02-07 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
73.649
+1.5%
9,29684.199 USD |
73.649 +1.5% | 9,29 | 684.199 USD | |
| 2025-02-03 | 2025-02-03 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
14.562
+0.3%
9,22134.262 USD |
14.562 +0.3% | 9,22 | 134.262 USD | |
| 2025-02-03 | 2025-01-31 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
11.754
+0.2%
8,89104.493 USD |
11.754 +0.2% | 8,89 | 104.493 USD | |
| 2025-02-03 | 2025-01-30 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
43.707
+0.9%
8,76382.873 USD |
43.707 +0.9% | 8,76 | 382.873 USD | |
| 2024-12-09 | 2024-12-09 | V Verkauf |
CHIEF EXECUTIVE OFFICER Geschäftsführender Verwaltungsratsmitglied |
7.627
-2.7%
9,7574.363 USD |
7.627 -2.7% | 9,75 | 74.363 USD | |
| 2024-11-27 | 2024-11-26 | V Verkauf |
CHIEF DEVELOPMENT OFFICER Führungsperson |
1.963
-2.1%
9,8719.378 USD |
1.963 -2.1% | 9,87 | 19.378 USD | |
| 2024-11-27 | 2024-11-26 | V Verkauf |
CHIEF MEDICAL OFFICER Führungsperson |
2.187
-2.2%
9,8721.586 USD |
2.187 -2.2% | 9,87 | 21.586 USD | |
| 2024-11-19 | 2024-11-18 | V Verkauf |
CHIEF EXECUTIVE OFFICER Geschäftsführender Verwaltungsratsmitglied |
14.400
-5.1%
9,26133.294 USD |
14.400 -5.1% | 9,26 | 133.294 USD | |
| 2024-11-19 | 2024-11-18 | V Verkauf |
CHIEF DEVELOPMENT OFFICER Führungsperson |
7.192
-7.4%
9,2666.573 USD |
7.192 -7.4% | 9,26 | 66.573 USD | |
| 2024-11-19 | 2024-11-18 | V Verkauf |
CHIEF MEDICAL OFFICER Führungsperson |
8.077
-7.9%
9,2674.766 USD |
8.077 -7.9% | 9,26 | 74.766 USD | |
| 2024-09-10 | 2024-09-09 | V Verkauf |
CHIEF EXECUTIVE OFFICER Geschäftsführender Verwaltungsratsmitglied |
7.352
-2.8%
12,1989.622 USD |
7.352 -2.8% | 12,19 | 89.622 USD | |
| 2024-08-26 | 2024-08-23 | V Verkauf |
CHIEF MEDICAL OFFICER Führungsperson |
2.135
-2.5%
12,4026.474 USD |
2.135 -2.5% | 12,40 | 26.474 USD | |
| 2024-08-26 | 2024-08-23 | V Verkauf |
CHIEF DEVELOPMENT OFFICER Führungsperson |
1.916
-2.2%
12,4023.758 USD |
1.916 -2.2% | 12,40 | 23.758 USD | |
| 2024-08-21 | 2024-08-19 | V Verkauf |
CHIEF EXECUTIVE OFFICER Geschäftsführender Verwaltungsratsmitglied |
14.215
-5.5%
12,01170.769 USD |
14.215 -5.5% | 12,01 | 170.769 USD | |
| 2024-08-21 | 2024-08-19 | V Verkauf |
CHIEF MEDICAL OFFICER Führungsperson |
7.973
-9.0%
12,0195.782 USD |
7.973 -9.0% | 12,01 | 95.782 USD | |
| 2024-08-21 | 2024-08-19 | V Verkauf |
CHIEF DEVELOPMENT OFFICER Führungsperson |
7.102
-7.8%
12,0185.318 USD |
7.102 -7.8% | 12,01 | 85.318 USD | |
| 2024-06-10 | 2024-06-07 | V Verkauf |
CHIEF EXECUTIVE OFFICER Geschäftsführender Verwaltungsratsmitglied |
7.465
-3.2%
11,5386.068 USD |
7.465 -3.2% | 11,53 | 86.068 USD | |
| 2024-05-21 | 2024-05-20 | V Verkauf |
CHIEF EXECUTIVE OFFICER Geschäftsführender Verwaltungsratsmitglied |
21.959
-9.2%
11,76258.337 USD |
21.959 -9.2% | 11,76 | 258.337 USD | |
| 2024-05-21 | 2024-05-20 | V Verkauf |
CHIEF DEVELOPMENT OFFICER Führungsperson |
11.610
-12.7%
11,76136.586 USD |
11.610 -12.7% | 11,76 | 136.586 USD | |
| 2024-05-21 | 2024-05-20 | V Verkauf |
CHIEF MEDICAL OFFICER Führungsperson |
13.175
-15.8%
11,76154.997 USD |
13.175 -15.8% | 11,76 | 154.997 USD | |
| 2024-05-21 | 2024-05-20 | V Verkauf |
CHIEF SCIENTIFIC OFFICER Führungsperson |
8.088
-10.0%
11,7695.151 USD |
8.088 -10.0% | 11,76 | 95.151 USD | |
| 2024-02-21 | 2024-02-20 | V Verkauf |
CHIEF MEDICAL OFFICER Führungsperson |
14.295
-21.3%
14,12201.774 USD |
14.295 -21.3% | 14,12 | 201.774 USD | |
| 2024-02-21 | 2024-02-20 | V Verkauf |
CFO, CBO Führungsperson |
22.802
-10.9%
14,11321.846 USD |
22.802 -10.9% | 14,11 | 321.846 USD | |
| 2024-02-21 | 2024-02-20 | GV Geplanter Verkauf |
CHIEF SCIENTIFIC OFFICER Führungsperson |
300
-0.5%
14,724.416 USD |
300 -0.5% | 14,72 | 4.416 USD | |
| 2024-02-21 | 2024-02-20 | GV Geplanter Verkauf |
CHIEF SCIENTIFIC OFFICER Führungsperson |
19.591
-23.9%
14,04274.991 USD |
19.591 -23.9% | 14,04 | 274.991 USD | |
| 2024-02-21 | 2024-02-20 | V Verkauf |
CHIEF SCIENTIFIC OFFICER Führungsperson |
8.397
-9.3%
14,11118.522 USD |
8.397 -9.3% | 14,11 | 118.522 USD | |
| 2024-02-21 | 2024-02-20 | V Verkauf |
CHIEF DEVELOPMENT OFFICER Führungsperson |
12.053
-14.2%
14,11170.124 USD |
12.053 -14.2% | 14,11 | 170.124 USD | |
| 2024-02-21 | 2024-02-20 | V Verkauf |
CEO Geschäftsführender Verwaltungsratsmitglied |
24.888
-10.5%
14,11351.289 USD |
24.888 -10.5% | 14,11 | 351.289 USD | |
| 2024-02-16 | 2024-02-14 | V Verkauf |
CHIEF DEVELOPMENT OFFICER Führungsperson |
39.886
-37.6%
15,01598.661 USD |
39.886 -37.6% | 15,01 | 598.661 USD | |
| 2024-02-16 | 2024-02-14 | V Verkauf |
CFO, CBO Führungsperson |
40.855
-20.4%
15,01613.205 USD |
40.855 -20.4% | 15,01 | 613.205 USD | |
| 2024-02-16 | 2024-02-14 | V Verkauf |
CEO Geschäftsführender Verwaltungsratsmitglied |
58.356
-24.3%
15,01875.883 USD |
58.356 -24.3% | 15,01 | 875.883 USD | |
| 2024-02-16 | 2024-02-14 | V Verkauf |
CHIEF SCIENTIFIC OFFICER Führungsperson |
28.171
-28.2%
15,01422.827 USD |
28.171 -28.2% | 15,01 | 422.827 USD | |
| 2024-02-08 | 2024-02-08 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
29.747
+0.6%
14,70437.281 USD |
29.747 +0.6% | 14,70 | 437.281 USD | |
| 2024-02-08 | 2024-02-07 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
51.827
+1.1%
14,56754.601 USD |
51.827 +1.1% | 14,56 | 754.601 USD | |
| 2024-02-08 | 2024-02-06 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
4.474
+0.1%
14,7465.947 USD |
4.474 +0.1% | 14,74 | 65.947 USD | |
| 2024-02-05 | 2024-02-01 | GV Geplanter Verkauf |
CEO Geschäftsführender Verwaltungsratsmitglied |
700
-0.6%
16,8111.770 USD |
700 -0.6% | 16,81 | 11.770 USD | |
| 2024-02-05 | 2024-02-01 | GV Geplanter Verkauf |
CEO Geschäftsführender Verwaltungsratsmitglied |
9.300
-7.3%
16,18150.428 USD |
9.300 -7.3% | 16,18 | 150.428 USD | |
| 2024-02-01 | 2024-01-30 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
88.099
+1.9%
14,471.274.793 USD |
88.099 +1.9% | 14,47 | 1.274.793 USD | |
| 2024-01-29 | 2024-01-29 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
80.600
+1.8%
14,221.146.132 USD |
80.600 +1.8% | 14,22 | 1.146.132 USD | |
| 2024-01-29 | 2024-01-26 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
4.174
+0.1%
12,9854.179 USD |
4.174 +0.1% | 12,98 | 54.179 USD | |
| 2024-01-29 | 2024-01-25 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
7.030
+0.2%
12,7389.492 USD |
7.030 +0.2% | 12,73 | 89.492 USD | |
| 2024-01-24 | 2024-01-24 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
20.686
+0.5%
12,44257.334 USD |
20.686 +0.5% | 12,44 | 257.334 USD | |
| 2024-01-24 | 2024-01-23 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
10.897
+0.2%
12,54136.648 USD |
10.897 +0.2% | 12,54 | 136.648 USD | |
| 2024-01-24 | 2024-01-22 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
67.546
+1.5%
12,55847.702 USD |
67.546 +1.5% | 12,55 | 847.702 USD | |
| 2024-01-19 | 2024-01-19 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
25.000
+0.6%
12,43310.750 USD |
25.000 +0.6% | 12,43 | 310.750 USD | |
| 2024-01-19 | 2024-01-18 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
39.680
+0.9%
12,51496.397 USD |
39.680 +0.9% | 12,51 | 496.397 USD | |
| 2024-01-19 | 2024-01-17 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
78.925
+1.8%
12,60994.455 USD |
78.925 +1.8% | 12,60 | 994.455 USD | |
| 2024-01-16 | 2024-01-16 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
19.599
+0.5%
12,73249.495 USD |
19.599 +0.5% | 12,73 | 249.495 USD | |
| 2024-01-16 | 2024-01-11 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
6.647
+0.2%
12,6884.284 USD |
6.647 +0.2% | 12,68 | 84.284 USD | |
| 2024-01-12 | 2024-01-11 | GV Geplanter Verkauf |
Chief Scientific Officer Führungsperson |
22.679
-36.3%
13,03295.514 USD |
22.679 -36.3% | 13,03 | 295.514 USD | |
| 2024-01-10 | 2024-01-10 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
47.700
+1.1%
12,67604.359 USD |
47.700 +1.1% | 12,67 | 604.359 USD | |
| 2024-01-10 | 2024-01-09 | GV Geplanter Verkauf |
Chief Scientific Officer Führungsperson |
100
-0.2%
13,001.300 USD |
100 -0.2% | 13,00 | 1.300 USD | |
| 2024-01-10 | 2024-01-09 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
20.816
+0.5%
12,56261.449 USD |
20.816 +0.5% | 12,56 | 261.449 USD | |
| 2024-01-10 | 2024-01-08 | GV Geplanter Verkauf |
Chief Scientific Officer Führungsperson |
17.221
-21.6%
13,01224.000 USD |
17.221 -21.6% | 13,01 | 224.000 USD | |
| 2024-01-10 | 2024-01-08 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
69.184
+1.7%
12,44860.649 USD |
69.184 +1.7% | 12,44 | 860.649 USD | |
| 2024-01-05 | 2024-01-04 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
41.764
+1.0%
12,11505.762 USD |
41.764 +1.0% | 12,11 | 505.762 USD | |
| 2024-01-05 | 2024-01-03 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
17.605
+0.4%
12,20214.781 USD |
17.605 +0.4% | 12,20 | 214.781 USD | |
| 2023-12-29 | 2023-12-29 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
6.013
+0.1%
12,4975.102 USD |
6.013 +0.1% | 12,49 | 75.102 USD | |
| 2023-12-29 | 2023-12-28 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
471.490
+13.0%
12,505.893.625 USD |
471.490 +13.0% | 12,50 | 5.893.625 USD | |
| 2023-12-29 | 2023-12-27 | K Kauf |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
41.514
+1.2%
11,97496.923 USD |
41.514 +1.2% | 11,97 | 496.923 USD | |
| 2023-12-28 | 2023-12-27 | GV Geplanter Verkauf |
CEO Geschäftsführender Verwaltungsratsmitglied |
30.000
-19.0%
12,02360.453 USD |
30.000 -19.0% | 12,02 | 360.453 USD | |
| 2023-11-21 | 2023-11-20 | V Verkauf |
Chief Scientific Officer Führungsperson |
4.958
-5.8%
8,2340.801 USD |
4.958 -5.8% | 8,23 | 40.801 USD | |
| 2023-11-21 | 2023-11-20 | V Verkauf |
President, CFO, CBO & Sec'y Führungsperson |
13.008
-10.4%
8,23107.047 USD |
13.008 -10.4% | 8,23 | 107.047 USD | |
| 2023-11-21 | 2023-11-20 | V Verkauf |
CEO Geschäftsführender Verwaltungsratsmitglied |
14.807
-8.6%
8,23121.851 USD |
14.807 -8.6% | 8,23 | 121.851 USD |